I. Flechner
- Immunology top 10%
- Immune Cell Function and Interaction 3
- Immune Response and Inflammation 3
- Immunotherapy and Immune Responses 2
- Endocrinology top 10%
- Surgery top 10%
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 2
- Genetics top 10%
-
- Glycosylation and Glycoproteins Research 2
-
- Neonatal Health and Biochemistry 2
-
- Erythrocyte Function and Pathophysiology 2
-
- Chemokine receptors and signaling 2
- Co-authors
- Uri GaliliE. A. RachmilewitzAviva PelegYael Stern-BachShimon SchuldinerEliezer A. RachmilewitzAhuva KnyszynskiD. Danon
- Cited by
- ImmunologyEndocrinologySurgery
- Journals
- Life Sciences (3 papers)Journal of Immunological Methods (2 papers)Endocrine Research (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
I. Flechner
20 papers receiving 882 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Immunology 271
- Endocrinology 55
- Surgery 466
- Immunology and Allergy 50
- Genetics 211
Countries citing papers authored by I. Flechner
This map shows the geographic impact of I. Flechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Flechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Flechner more than expected).
Fields of papers citing papers by I. Flechner
This network shows the impact of papers produced by I. Flechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Flechner. The network helps show where I. Flechner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Flechner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 9 | |
| 2 | 1992 | 8 | |
| 3 | 1992 | 4 | |
| 4 | 1992 | 11 | |
| 5 | 1992 | 9 | |
| 6 | The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist. | 1991 | 16 |
| 7 | 1991 | 3 | |
| 8 | Effects of radical scavengers on the development of experimental diabetes. | 1990 | 21 |
| 9 | 1990 | 17 | |
| 10 | 1990 | 60 | |
| 11 | 1986 | 74 | |
| 12 | A naturally occurring anti-alpha-galactosyl IgG recognizing senescent human red cells. | 1985 | 8 |
| 13 | A unique natural human IgG antibody with anti-alpha-galactosyl specificity.breakdown → | 1984 | 579 |
| 14 | 1973 | 37 | |
| 15 | 1971 | 69 | |
| 16 | 1970 | 1 | |
| 17 | 1970 | 1 | |
| 18 | 1968 | 1 | |
| 19 | 1966 | 2 | |
| 20 | 1964 | 5 |
About I. Flechner
I. Flechner is a scholar working on Biological Psychiatry, Immunology, Immunology and Allergy, Developmental Neuroscience and Physiology, having authored 20 papers that have together received 935 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (3 papers), Immune Response and Inflammation (3 papers), Glycosylation and Glycoproteins Research (2 papers), Neonatal Health and Biochemistry (2 papers), Erythrocyte Function and Pathophysiology (2 papers), Chemokine receptors and signaling (2 papers), Immunotherapy and Immune Responses (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Immunology (271 citations), Endocrinology (55 citations), Surgery (466 citations), Immunology and Allergy (50 citations) and Genetics (211 citations). I. Flechner has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Uri Galili, E. A. Rachmilewitz, Aviva Peleg, Yael Stern-Bach, Shimon Schuldiner, Eliezer A. Rachmilewitz, Ahuva Knyszynski, D. Danon, E. Lederer and E. Vilkas. Their work appears in journals such as Life Sciences, Journal of Immunological Methods, Endocrine Research, British Journal of Haematology and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.